You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Market News

Market News

HomeMarket NewsInformation about Individual Stocks

AIM Vaccine Co., Ltd. (06660)

AIM Vaccine Co., Ltd. engages in the research and development, manufacturing, and commercialization of vaccine products for human use in the People's Republic of China. The company markets vaccine products, including recombinant Hepatitis B vaccine (Hansenula Polymorpha); freeze-dried Human R rabies vaccine; inactivated hepatitis A virus vaccines (human diploid cell); live attenuated parotiti s vaccine; inactived HFRS Vacci